Literature DB >> 33249518

Improved detection of sentinel lymph node metastases allows reliable intraoperative identification of patients with extended axillary lymph node involvement in early breast cancer.

Cristina L Cotarelo1, Annemarie Zschöck-Manus2, Marcus Schmidt3, Arno Schad2, Christoph Brochhausen4, Charles James Kirkpatrick2, Sonja Thaler5.   

Abstract

BACKGROUND: An improved procedure that allows accurate detection of negative sentinel lymph node (SLN) and of SLN macrometastases during surgery would be highly desirable in order to protect patients from further surgery and to avoid unnecessary costs. We evaluated the accuracy of an intraoperative procedure that combines touch imprint cytology (TIC) and subsequent frozen section (FS) analysis. 2276 SLNs from 1072 patients with clinical node-negative early breast cancer were evaluated during surgery using TIC. Only cytologically-positive SLN were subsequently analysed with a single FS, preserving cytologically-negative SLN for the final postoperative histological diagnosis. Sensitivity, specificity and the accuracy of this approach were analysed by comparing the results from intra- and postoperative SLN and axillary node evaluation. This intraoperative method displayed 100% specificity for SLN metastases and was significantly more sensitive for prognostically relevant macrometastases (85%) than for micrometastases (10%). Sensitivity was highest for patients with two or more positive LNs (96%) than for those with only one (72%). 98% of the patients with final pN2a-pN3a were already identified during surgery. Patients who received primary axillary lymph node dissection had significantly more frequent metastases in further LNs (44.6%). Sensitivity was highest for patients with luminal-B, HER2+ and triple negative breast cancer and for any subtype if Ki-67 > 40%. TIC and subsequent FS of cytologically-positive SLNs is highly reliable for detection of SLN macrometastases, and allows accurate identification of patients with a high risk of extended axillary involvement during surgery, as well as accurate histological diagnosis of negative SLN.

Entities:  

Keywords:  Frozen section; Metastases; Sentinel lymph node; Touch imprint cytology

Mesh:

Year:  2020        PMID: 33249518      PMCID: PMC7882580          DOI: 10.1007/s10585-020-10065-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  33 in total

1.  St. Gallen 2013: brief preliminary summary of the consensus discussion.

Authors:  Nadia Harbeck; Christoph Thomssen; Michael Gnant
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

2.  Use of intraoperative stereomicroscopy for preventing loss of metastases during frozen sectioning of sentinel lymph nodes in breast cancer.

Authors:  Z Varga; C Rageth; E Saurenmann; C Honegger; S von Orelli; M Fehr; D Fink; B Seifert; H Moch; R Caduff
Journal:  Histopathology       Date:  2008-04       Impact factor: 5.087

3.  St. Gallen 2011: Summary of the Consensus Discussion.

Authors:  Michael Gnant; Nadia Harbeck; Christoph Thomssen
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

Review 4.  Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale.

Authors:  Donald L Weaver
Journal:  Mod Pathol       Date:  2010-05       Impact factor: 7.842

5.  Application of ACOSOG Z0011 criteria reduces perioperative costs.

Authors:  Melissa S Camp; Rachel A Greenup; Alphonse Taghian; Suzanne B Coopey; Michelle Specht; Michele Gadd; Kevin Hughes; Barbara L Smith
Journal:  Ann Surg Oncol       Date:  2012-09-26       Impact factor: 5.344

6.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

Review 7.  Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.

Authors:  Srila Samphao; Jennifer M Eremin; Mohamed El-Sheemy; Oleg Eremin
Journal:  Ann Surg Oncol       Date:  2008-03-11       Impact factor: 5.344

8.  Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Gary H Lyman; Mark R Somerfield; Linda D Bosserman; Cheryl L Perkins; Donald L Weaver; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2016-12-12       Impact factor: 44.544

9.  Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.

Authors:  Gary H Lyman; Sarah Temin; Stephen B Edge; Lisa A Newman; Roderick R Turner; Donald L Weaver; Al B Benson; Linda D Bosserman; Harold J Burstein; Hiram Cody; James Hayman; Cheryl L Perkins; Donald A Podoloff; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

10.  Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.

Authors:  Armando E Giuliano; Karla Ballman; Linda McCall; Peter Beitsch; Pat W Whitworth; Peter Blumencranz; A Marilyn Leitch; Sukamal Saha; Monica Morrow; Kelly K Hunt
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.